Home
Home » companies

Salix

Strong Relistor Sales Drive New Rally In Progenics

Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha

Salix Pharmaceuticals Price Target Raised to $53.00 at Brean Murray (SLXP)

Salix Pharmaceuticals Price Target Raised to $53.00 at Brean Murray (SLXP)
Jags Report

Salix scores FDA approval for HIV-related diarrhea drug Fulyzaq

Salix scores FDA approval for HIV-related diarrhea drug Fulyzaq
FierceMedicalDevice

This Week in Biotech: Part 2

This Week in Biotech: Part 2
Motley Fool

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville

3 Highly Liquid Drugmakers Undervalued By EPS Trends

3 Highly Liquid Drugmakers Undervalued By EPS Trends
Seeking Alpha

Salix Pharmaceuticals: Hot Biotech For Long-Term Growth

Salix Pharmaceuticals: Hot Biotech For Long-Term Growth
Seeking Alpha

Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha

Salix Pharmaceuticals Beats, Announces Licensing Deal

Salix Pharmaceuticals Beats, Announces Licensing Deal
Investors.com

Progenics Plummets On Rejection Of New Use Of Relistor Drug

Progenics Plummets On Rejection Of New Use Of Relistor Drug
Bloomberg